Form 144 - Report of proposed sale of securities:
SEC Accession No. 0001950047-25-010713
Filing Date
2025-12-29
Accepted
2025-12-29 09:38:24
Documents
1

Document Format Files

Seq Description Document Type Size
1 primary_doc.html 144  
1 primary_doc.xml 144 7479
  Complete submission text file 0001950047-25-010713.txt   9116
Mailing Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130
Business Address 3611 VALLEY CENTRE DR SUITE 300 SAN DIEGO CA 92130 888-969-7879
Travere Therapeutics, Inc. (Subject) CIK: 0001438533 (see all company filings)

EIN.: 262383102 | State of Incorp.: CA | Fiscal Year End: 1231
Type: 144 | Act: 33 | File No.: 001-36257 | Film No.: 251604354
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)

Mailing Address 3611 VALLEY CENTER DRIVE SUITE 300 SAN DIEGO CA 92130
Business Address
Calvin Sandra (Reporting) CIK: 0001882909 (see all company filings)

Type: 144